Michael Blaszyk is listed as a director on 4 SEC Form D filings by 2 issuers between Aug 2015 and Sep 2023: ImmunityBio, Inc. (San Diego, CA — biotechnology — 2015–2023; $470M reported sold to 48 investors) and NantHealth, Inc. (Culver City, CA — other technology — 2021; $200M reported sold to 23 investors).
What this means 2 separate companies raised money with this person listed as director, over about 8 years. Across those companies the filings report $670M sold in total.
Listed alongside Patrick Soon-Shiong (3 shared filings), Barry Simon (2 shared filings), Cheryl Cohen (2 shared filings), Christobel Selecky (2 shared filings), David Sachs (2 shared filings) and 19 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.
1 of the issuers belongs to the sponsor group Nanthealth (2 issuers, $197.5M reported sold, 2013–2021).
What this means A sponsor group is one team that sets up a new company for each deal. Nanthealth has 2 companies on file and $197.5M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 2 court cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for Michael Blaszyk and found 3 differences: Form D filed 27 days after the first sale; Same name, different state: "Michael Blaszyk" (IL) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.